Blueprint Medicines Change in Accounts Receivable 2014-2025 | BPMC
Blueprint Medicines change in accounts receivable for the twelve months ending March 31, 2025 was $-0.099B, a 73.51% increase year-over-year.
- Blueprint Medicines annual change in accounts receivable for 2024 was $-0.033B, a 327.2% increase from 2023.
- Blueprint Medicines annual change in accounts receivable for 2023 was $-0.008B, a 242.92% increase from 2022.
- Blueprint Medicines annual change in accounts receivable for 2022 was $-0.002B, a 81.09% decline from 2021.